New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures Post author:Sam Post published:January 2, 2018 Post category:BioPharma The round was co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures. Source: BioSpace You Might Also Like Bay Area's Portola Rockets as the FDA Approves First and Only Anticoagulant for Hospitals June 25, 2017 Spark Therapeutics Jumps as FDA Panel Backs Breakthrough Gene Therapy October 12, 2017 Acorda Investor Urges for Company to Explore Sale August 6, 2017
Bay Area's Portola Rockets as the FDA Approves First and Only Anticoagulant for Hospitals June 25, 2017